Buprenorphine And Naloxone Tablet
Product Images NDC 71335-1378

4 FDA label images from Bryant Ranch Prepack · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Buprenorphine And Naloxone (NDC 71335-1378). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Buprenorphine Chemical Structure (Buprenorphine And Naloxone Sublingual Tablets 1)

Buprenorphine Chemical Structure (Buprenorphine And Naloxone Sublingual Tablets 1)
Chemical structure of Buprenorphine, depicted with associated atoms and bonds, including a hydrochloride (HCl) notation indicating the salt form.*
FDA Label Image

Naloxone Chemical Structure (Buprenorphine And Naloxone Sublingual Tablets 2)

Naloxone Chemical Structure (Buprenorphine And Naloxone Sublingual Tablets 2)
Chemical structure of Buprenorphine, an active ingredient in the combination product Buprenorphine and Naloxone.*
FDA Label Image

Image (Buprenorphine And Naloxone Sublingual Tablets 3)

Image (Buprenorphine And Naloxone Sublingual Tablets 3)
An instructional illustration showing a person placing a sublingual tablet under the tongue. The image emphasizes correct administration by depicting an open mouth with visible teeth and the tablet being positioned below the tongue, highlighting proper use for sublingual tablets.*
FDA Label Image

Label (Lbl713351378)

Label (Lbl713351378)
Label for Buprenorphine and Naloxone 8 mg/2 mg sublingual tablets by Bryant Ranch Prepack. The label specifies a pink hexagon (6 sided) tablet shape, includes storage instructions to keep tightly closed and store at room temperature (20°-25°C). It notes comparison to Suboxone 8 mg/2 mg sublingual tablets by Lannett Company Inc. and displays NDC 71335-1378-1.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.